Growth hormone therapy at the time of Covid 19 pandemic: adherence and drug supply issues

Due to the outbreak of Covid-2019 pandemic, the organisation of many Hospitals in Italy, as well as all over the world, has changed dramatically. In our tertiary Endocrinology Unit, we are continuing to deliver urgent care to our patients, trying to grant assistance to chronic and frail subjects, as well. In this Letter, we provide a picture of GH adherence during Covid19 pandemic form one of the first and worst hit Italian region. We aim to share our experience in the management of both paediatric and adult patients with growth hormone deficiency, enlightening that every possible effort is valuable to reduce the risk of therapy discontinuation.